LU91305I2 - A tryn-antithrombin alfa - Google Patents

A tryn-antithrombin alfa

Info

Publication number: LU91305I2
Authority: LU; Luxembourg
Prior art keywords: milk; permeate; tryn; procedure; antithrombin alfa
Prior art date: 1996-05-13

Application number

LU91305C

Other languages

English (en)

French (fr)

Original Assignee

Gtc Biotherapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-13

Filing date

2007-01-12

Publication date

2007-03-12

2007-01-12 Application filed by Gtc Biotherapeutics Inc filed Critical Gtc Biotherapeutics Inc

2007-03-12 Publication of LU91305I2 publication Critical patent/LU91305I2/fr

Links

229960002843 antithrombin alfa Drugs 0.000 title 1
239000008267 milk Substances 0.000 abstract 7
210000004080 milk Anatomy 0.000 abstract 7
235000013336 milk Nutrition 0.000 abstract 7
238000000034 method Methods 0.000 abstract 4
239000012466 permeate Substances 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
239000002738 chelating agent Substances 0.000 abstract 1
238000009295 crossflow filtration Methods 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
238000000746 purification Methods 0.000 abstract 1
239000012465 retentate Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
230000009261 transgenic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/832—Milk; colostrum

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biochemistry (AREA)
Organic Chemistry (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Analytical Chemistry (AREA)
Health & Medical Sciences (AREA)
Food Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Polymers & Plastics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

LU91305C 1996-05-13 2007-01-12 A tryn-antithrombin alfa LU91305I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/648,235 US6268487B1 (en)	1996-05-13	1996-05-13	Purification of biologically active peptides from milk
PCT/US1997/008044 WO1997042835A1 (en)	1996-05-13	1997-05-13	Purification of biologically active peptides from milk

Publications (1)

Publication Number	Publication Date
LU91305I2 true LU91305I2 (fr)	2007-03-12

Family

ID=24599969

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU91305C LU91305I2 (fr)	1996-05-13	2007-01-12	A tryn-antithrombin alfa

Country Status (14)

Country	Link
US (1)	US6268487B1 (2)
EP (1)	EP0923308B1 (2)
JP (1)	JP4476362B2 (2)
AT (1)	ATE224145T1 (2)
AU (1)	AU725993B2 (2)
CA (1)	CA2254871C (2)
DE (2)	DE69715641T2 (2)
DK (1)	DK0923308T3 (2)
ES (1)	ES2182074T3 (2)
LU (1)	LU91305I2 (2)
NL (1)	NL300256I2 (2)
NZ (1)	NZ332916A (2)
PT (1)	PT923308E (2)
WO (1)	WO1997042835A1 (2)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE122007000007I1 (de)	1986-04-09	2007-05-16	Genzyme Corp	Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
WO1999020766A2 (en)	1997-10-20	1999-04-29	Genzyme Transgenics Corporation	NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
SE9802213D0 (sv) *	1998-06-18	1998-06-18	Amersham Pharm Biotech Ab	A method for the removal/purification of serum albumins and means for use in the method
US20030005468A1 (en) *	1998-06-19	2003-01-02	Meade Harry M.	Methods and vectors for improving nucleic acid expression
ATE328007T1 (de) *	1998-09-24	2006-06-15	Pharming Intellectual Pty Bv	Reinigung von fibrinogen aus flüssigkeiten mittels ausfällung und hydrophobischer- interaktion-chromatographie
EP1148779B1 (en) *	1999-01-06	2007-12-12	Merrimack Pharmaceuticals, Inc.	Expression of secreted human alpha-fetoprotein in transgenic animals
WO2001000855A1 (en)	1999-06-23	2001-01-04	Ppl Therapeutics (Scotland) Ltd.	Fusion proteins incorporating lysozyme
HUP0302396A2 (hu) *	2000-05-05	2003-10-28	Gtc Biotherapeutics, Inc.	Transzgénikus úton előállított dekorin
US20020077775A1 (en) *	2000-05-25	2002-06-20	Schork Nicholas J.	Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20030195707A1 (en) *	2000-05-25	2003-10-16	Schork Nicholas J	Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20040226052A1 (en) *	2000-10-13	2004-11-11	Meade Harry M.	Methods of producing a target molecule in a transgenic animal and purification of the target molecule
US20030036637A1 (en) *	2001-06-13	2003-02-20	Scott Fulton	Purification of human serum albumin
WO2003014151A2 (en) *	2001-08-10	2003-02-20	Genset S.A.	Human secreted proteins, their encoding polynucleotides, and uses thereof
US6875459B2 (en) *	2001-09-10	2005-04-05	Henry B. Kopf	Method and apparatus for separation of milk, colostrum, and whey
US20060253913A1 (en) *	2001-12-21	2006-11-09	Yue-Jin Huang	Production of hSA-linked butyrylcholinesterases in transgenic mammals
WO2003090545A1 (en) *	2002-04-24	2003-11-06	Dairy Development Specialists, Inc.	Intermediate ingredient for dairy product manufacturing and method of making the same
EP1367065B1 (en) *	2002-05-27	2008-07-30	Nestec S.A.	Acid soluble proteins from micellar casein
GB0216001D0 (en) *	2002-07-10	2002-08-21	Nat Blood Authority	Process and composition
WO2004026427A2 (en) *	2002-09-17	2004-04-01	Gtc Biotherapeutics, Inc.	Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
BR0316643A (pt) *	2002-11-27	2005-10-11	Gtc Biotherapeutics Inc	Anticorpos modificados estavelmente produzidos no leite e método de produzir os mesmos
US20040231010A1 (en) *	2003-01-09	2004-11-18	Murray James D.	Lysozyme transgenic ungulates
US20040210953A1 (en) *	2003-01-09	2004-10-21	Murray James D.	Lysozyme transgenic ungulates
ATE521701T1 (de)	2003-01-22	2011-09-15	Univ Duke	Verbesserte konstrukte zur expression lysosomaler polypeptide
CA2516836A1 (en) *	2003-02-24	2004-09-10	Gtc Biotherapeutics, Inc.	Methods of tangential flow filtration and an apparatus therefore
WO2005085287A1 (en)	2004-03-03	2005-09-15	En-N-Tech, Inc.	Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
US20050197496A1 (en) *	2004-03-04	2005-09-08	Gtc Biotherapeutics, Inc.	Methods of protein fractionation using high performance tangential flow filtration
US20050245444A1 (en) *	2004-04-30	2005-11-03	Yann Echelard	Method of using recombinant human antithrombin for neurocognitive disorders
US20060121004A1 (en) *	2004-12-07	2006-06-08	Yann Echelard	Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
US20060130159A1 (en) *	2004-12-09	2006-06-15	Nick Masiello	Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
US20080019905A9 (en) *	2005-02-18	2008-01-24	Strome Scott E	Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
WO2006138647A2 (en) *	2005-06-16	2006-12-28	Gtc Biotherapeutics, Inc.	Method of making recombinant human antibodies for use in biosensor technology
WO2007014244A2 (en) *	2005-07-25	2007-02-01	Gtc Biotherapeutics, Inc.	Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile
KR20080068089A (ko) *	2005-10-21	2008-07-22	지티씨바이오쎄라퓨틱스,인크.	항체 의존성 세포 독성 활성이 증강된 항체, 그 생산 및사용 방법
US7531632B2 (en) *	2006-02-16	2009-05-12	Gtc Biotherapeutics, Inc.	Clarification of transgenic milk using depth filtration
FR2901707B1 (fr) *	2006-05-31	2017-09-29	Lab Francais Du Fractionnement	Composition de facteur vii recombinant ou transgenique, chaque molecule de facteur vii possedant deux sites de n-glycosylation a motifs glycanniques definis
US20090208480A1 (en) *	2006-08-04	2009-08-20	Yue Huang	Long half-life recombinant butyrylcholinesterase
FR2910786B1 (fr) *	2006-12-29	2017-08-11	Laboratoire Francais Du Fractionnement Et Des Biotechnologies (Lfb)	"procede d'extraction d'une proteine presente dans du lait"
JP5208428B2 (ja) *	2007-01-30	2013-06-12	雪印メグミルク株式会社	美肌剤
FR2912310B1 (fr)	2007-02-13	2009-08-07	Kasan Sarl	Nouvelles compositions cosmetiques et/ou pharmaceutiques et leurs applications.
US7919589B2 (en)	2007-07-10	2011-04-05	Glanbia Nutritionals (Ireland), Ltd.	Method for removing endotoxin from proteins
EP2077273B1 (en)	2007-12-31	2011-09-14	Animal Technology Institute Taiwan	Methods for separating casein from soluble proteins in a composition
TWI346666B (en) *	2007-12-31	2011-08-11	Animal Technology Inst Taiwan	Method for seperating casein from casein-contained solution
CN102014656B (zh) *	2008-04-21	2014-07-23	不二制油株式会社	脱脂豆乳肽的制备方法
WO2009134389A2 (en) *	2008-05-01	2009-11-05	Gtc Biotherapeutics, Inc.	An anti-cd137 antibody as an agent in the treatment of inflammatory conditions
EP2293678A4 (en) *	2008-05-14	2011-06-22	Agriculture Victoria Serv Pty	ANGIOGENIC-ENRICHED MILK FRACTIONS
CN104193798A (zh) *	2009-12-18	2014-12-10	Csl有限公司	纯化多肽的方法
JP2013526840A (ja)	2009-12-21	2013-06-27	ファーマシーネ，インコーポレイテッド	組み換えブチリルコリンエステラーゼおよびその切断型
US8861162B2 (en) *	2010-03-09	2014-10-14	Honeywell International Inc.	High power solid state power controller (SSPC) solution for primary power distribution applications
CN104959087B (zh)	2010-04-09	2017-08-15	帕西拉制药有限公司	用于配制大直径合成膜囊泡的方法
FR2958496A1 (fr) *	2010-04-09	2011-10-14	Bioprotein Technologies Sa	Preparation de proteine plasmatique de transfert des phospholipides (pltp) humaine recombinante a partir du lait d'animaux transgeniques.
CN107190034A (zh) *	2010-10-05	2017-09-22	诺沃—诺迪斯克保健股份有限公司	生产蛋白质的方法
KR20140093603A (ko)	2010-12-30	2014-07-28	라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스	병원체 불활성화제로서의 글리콜
CN105413480B (zh)	2011-04-01	2019-03-29	Emd密理博公司	含有纳米纤维的复合材料结构
KR20140054026A (ko) *	2011-07-07	2014-05-08	알에보 바이올로직스, 인코포레이티드	단백질을 안정화시키는 제제
TW201400499A (zh)	2012-03-12	2014-01-01	Revo Biolog Inc	抗凝血酶用於治療妊娠毒血症之用途
EP2687595B1 (en)	2012-07-19	2018-05-30	Laboratoire Français du Fractionnement et des Biotechnologies	Method for purifying transgenic factor VII
TW201425332A (zh)	2012-08-03	2014-07-01	Revo Biolog Inc	抗凝血酶用於體外膜氧合之用途
US10034921B2 (en)	2013-02-13	2018-07-31	Laboratoire Français Du Fractionnement Et Des Biotechnologies	Proteins with modified glycosylation and methods of production thereof
EP3594231A1 (en)	2013-02-13	2020-01-15	Laboratoire Français du Fractionnement et des Biotechnologies	Highly galactosylated anti-tnf-alpha antibodies and uses thereof
MX384222B (es)	2013-07-05	2025-03-14	Lab Francais Du Fractionnement	Matriz de cromatografia de afinidad.
US9661868B2 (en) *	2013-07-16	2017-05-30	Mead Johnson Nutrition Company	Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin
AU2015270152A1 (en) *	2014-06-02	2016-12-08	Laboratoire Francais Du Fractionnement Et Des Biotechnologies	Production of Fc fragments
JP6568545B2 (ja)	2014-06-26	2019-08-28	イー・エム・デイー・ミリポア・コーポレイシヨン	増強された汚れ保持容量を有するフィルタ構造
FR3034419B1 (fr)	2015-04-02	2017-12-15	Lab Francais Du Fractionnement	Procede de purification d'une proteine recombinante therapeutique a partir d'un lait transgenique
EP3283202B1 (en) *	2015-04-17	2025-10-01	EMD Millipore Corporation	Method of purifying a biological materia of interest in a sample using nanofiber ultrafiltration membranes operated in tangential flow filtration mode
FR3038517B1 (fr)	2015-07-06	2020-02-28	Laboratoire Francais Du Fractionnement Et Des Biotechnologies	Utilisation de fragments fc modifies en immunotherapie
EP3655142B1 (en)	2017-07-21	2026-02-25	Merck Millipore Ltd	Non-woven fiber membranes
KR20210016400A (ko) *	2018-05-24	2021-02-15	지앙수 헨그루이 메디슨 컴퍼니 리미티드	재조합 인간 인슐린 또는 그 유사체의 전구체를 제조하는 방법
FR3082427B1 (fr)	2018-06-14	2020-09-25	Lab Francais Du Fractionnement	Combinaison de facteur vii et d'un anticorps bispecifique anti-facteurs ix et x
JP7478333B2 (ja) *	2020-07-29	2024-05-07	和弘原	成分調整物生産装置及び成分調整物生産方法
CN113101737B (zh) *	2021-03-04	2023-09-15	京美生命科技(杭州)有限公司	一种亲和切向流过滤系统及其构建方法和外泌体提取方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2459619B1 (fr)	1979-06-26	1983-07-29	Agronomique Inst Nat Rech	Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
FR2487642B2 (fr)	1980-07-31	1985-10-18	Bel Fromageries	Procede de preparation de fractions proteiques par ultrafiltration et chromatographie d'exclusion et d'echange d'ions
DE3432718C1 (de)	1984-09-06	1986-05-22	Biotest Pharma GmbH, 6000 Frankfurt	Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
FR2584727B1 (fr)	1985-07-11	1988-06-17	Roussel Uclaf	Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques
JPS62298536A (ja)	1986-06-17	1987-12-25	Green Cross Corp:The	生理活性物質の自動精製方法および自動精製装置
DE3743440A1 (de) *	1987-12-21	1989-06-29	Gauri Kailash Kumar	Verfahren zum trennen der geloesten und ungeloesten bestandteile von milch
US4897465A (en)	1988-10-12	1990-01-30	Abbott Laboratories	Enrichment and concentration of proteins by ultrafiltration
CA2075206C (en)	1989-12-01	2006-05-23	Herbert L. Heyneker	Production of recombinant polypeptides by bovine species and transgenic methods
NL9001650A (nl)	1990-07-19	1992-02-17	Ver Coop Melkind	Werkwijze voor de bereiding van een melkeiwit-isolaat.
US5256294A (en) *	1990-09-17	1993-10-26	Genentech, Inc.	Tangential flow filtration process and apparatus
US5175013A (en)	1990-12-31	1992-12-29	The Pillsbury Company	Frozen dessert compositions and products
US5178894A (en)	1991-09-26	1993-01-12	Silvia P. Rudel	High non-fat milk content bread products having improved keeping qualities
EP0652889A4 (en)	1992-06-15	1997-05-07	Gene Pharming Europ Bv	PRODUCTION OF RECOMBINANT POLYPEPTIDES BY BOVINE SPECIES AND TRANSGENIC PROCESSES.
US5256437A (en) *	1992-06-19	1993-10-26	Pall Corporation	Product and process of making sterile milk through dynamic microfiltration
DE69424687T2 (de)	1993-03-09	2000-09-07	Genzyme Corp., Cambridge	Verfahren zur isolierung von proteinen aus milch
ATE209862T1 (de)	1994-02-16	2001-12-15	Pharming Intellectual Pty Bv	Isolierung von lactoferrin aus milch
US5597486A (en) *	1995-05-01	1997-01-28	Millipore Investment Holdings Limited	Membrane filtration with optimized addition of second liquid to maximize flux

1996
- 1996-05-13 US US08/648,235 patent/US6268487B1/en not_active Expired - Lifetime
1997
- 1997-05-13 AU AU29402/97A patent/AU725993B2/en not_active Expired
- 1997-05-13 DE DE69715641T patent/DE69715641T2/de not_active Expired - Lifetime
- 1997-05-13 DK DK97923643T patent/DK0923308T3/da active
- 1997-05-13 PT PT97923643T patent/PT923308E/pt unknown
- 1997-05-13 ES ES97923643T patent/ES2182074T3/es not_active Expired - Lifetime
- 1997-05-13 EP EP97923643A patent/EP0923308B1/en not_active Expired - Lifetime
- 1997-05-13 AT AT97923643T patent/ATE224145T1/de active
- 1997-05-13 JP JP54103697A patent/JP4476362B2/ja not_active Expired - Lifetime
- 1997-05-13 CA CA002254871A patent/CA2254871C/en not_active Expired - Lifetime
- 1997-05-13 DE DE122007000008C patent/DE122007000008I2/de active Active
- 1997-05-13 NZ NZ332916A patent/NZ332916A/xx not_active IP Right Cessation
- 1997-05-13 WO PCT/US1997/008044 patent/WO1997042835A1/en not_active Ceased
2007
- 2007-01-12 LU LU91305C patent/LU91305I2/fr unknown
- 2007-01-19 NL NL300256C patent/NL300256I2/nl unknown

Also Published As

Publication number	Publication date
JP2000510701A (ja)	2000-08-22
NZ332916A (en)	2000-05-26
DE122007000008I2 (de)	2011-01-13
EP0923308A1 (en)	1999-06-23
DE122007000008I1 (de)	2009-05-20
PT923308E (pt)	2002-11-29
WO1997042835A1 (en)	1997-11-20
CA2254871C (en)	2008-03-25
EP0923308A4 (2)	1999-06-30
AU2940297A (en)	1997-12-05
ES2182074T3 (es)	2003-03-01
JP4476362B2 (ja)	2010-06-09
NL300256I1 (nl)	2007-04-02
DE69715641D1 (de)	2002-10-24
DK0923308T3 (da)	2002-10-14
AU725993B2 (en)	2000-10-26
NL300256I2 (nl)	2007-09-03
US6268487B1 (en)	2001-07-31
CA2254871A1 (en)	1997-11-20
EP0923308B1 (en)	2002-09-18
ATE224145T1 (de)	2002-10-15
DE69715641T2 (de)	2003-08-07

Publication	Publication Date	Title
LU91305I2 (fr)	2007-03-12	A tryn-antithrombin alfa
DE58903874D1 (de)	1993-04-29	Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration.
DK0552192T3 (da)	1995-07-17	Forbedret tangentialstrømningsfiltreringsfremgangsmåde og -apparat
DE3588254D1 (de)	2007-10-25	Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
IT1265012B1 (it)	1996-10-17	Procedimento per il trattamento di un fluido utilizzante microfiltrazione dinamica ed ultrafiltrazione.
DE69633563D1 (de)	2004-11-11	Neues verfahren zur gewinnung und reinigung von fusionsproteinen
DK426386D0 (da)	1986-09-05	Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer
EP1457460A3 (en)	2004-10-13	Water purification system and method, and module for the system
DK0764209T3 (da)	2001-03-19	Albuminekspression i gær
ATE138923T1 (de)	1996-06-15	Verfahren zur herstellung gereinigter glycolipide durch membrantrennverfahren
AR245012A1 (es)	1993-12-30	Un aparato mejorado para el ultra o microfiltrado de liquidos, especialmente agua.
DE3789309D1 (de)	1994-04-14	Enzymatische membran, verfahren zur herstellung und trennung von peptiden.
DE60220184D1 (de)	2007-06-28	Membranfilter, system diesen enthaltend, und verfahren zu dessen verwendung
GB2301367A (en)	1996-12-04	Method and apparatus for isolation and purification of biologically active complexes
ATE132905T1 (de)	1996-01-15	Methode der reinigung von proteinen
ATE211117T1 (de)	2002-01-15	Verfahren zur reinigung von alkalimetallsilikatlösungen
NO971474L (no)	1997-06-03	Anti-inflammatorisk faktor, fremgangsmåte for isolering, og anvendelse
ATE91304T1 (de)	1993-07-15	Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.
ATE215784T1 (de)	2002-04-15	Verfahren zur herstellung eines kappa-casein- glykomakropeptides oder eines abkoemmlings davon
RU96122514A (ru)	1998-10-10	Способ выделения бактериофагов
DK628188D0 (da)	1988-11-10	Protein og fremgangsmaade til fremstilling deraf
ATE72830T1 (de)	1992-03-15	Verfahren zur herstellung von gereinigter glukoseisomerase.
ATE228102T1 (de)	2002-12-15	Verfahren und vorrichtung zur trennung von biomasse und wasser
DE59807666D1 (de)	2003-04-30	Verfahren zum herstellen von nebenwirkungsfreien konstrastmitteln bei ultrafiltration
IT8421612A0 (it)	1984-06-26	Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.